USA · PI Dr. Rossi · activated
Patients
3
Active
0
Serious AEs
0
Open QA
0
Aged queries
0
Luna users
0
Studies & contracts
Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease.
Phase II · study completed · contract executed · 73500 USD
Patients (3)
Safety — 21 AEs, 0 serious
No serious adverse events.
QA findings (0 open)
No findings recorded.
Visits & payments
Nothing scheduled.
☾ Luna participants
No Luna participants here yet.